- Report
- August 2025
- 199 Pages
Global
From €3140EUR$3,545USD£2,762GBP
€3489EUR$3,939USD£3,069GBP
- Report
- August 2025
- 189 Pages
Global
From €3140EUR$3,545USD£2,762GBP
€3489EUR$3,939USD£3,069GBP
- Report
- April 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,498GBP
- Report
- August 2025
- 278 Pages
Global
From €5182EUR$5,850USD£4,558GBP
- Report
- December 2024
- 30 Pages
Global
From €2436EUR$2,750USD£2,143GBP
- Report
- December 2024
- 30 Pages
Global
From €2436EUR$2,750USD£2,143GBP
- Report
- December 2024
- 30 Pages
Global
From €2436EUR$2,750USD£2,143GBP
- Report
- October 2024
- 140 Pages
Global
From €2214EUR$2,500USD£1,948GBP
- Report
- February 2025
- 135 Pages
Global
From €13282EUR$14,995USD£11,684GBP
- Report
- January 2024
- 150 Pages
Global
From €5270EUR$5,950USD£4,636GBP
- Report
- April 2024
- 115 Pages
Global
From €3986EUR$4,500USD£3,506GBP
- Report
- August 2022
- 120 Pages
Global
From €3986EUR$4,500USD£3,506GBP
- Report
- July 2024
- 150 Pages
Global
From €3322EUR$3,750USD£2,922GBP
- Report
- June 2024
- 200 Pages
Global
From €7042EUR$7,950USD£6,194GBP
- Report
- June 2023
- 200 Pages
Global
From €6643EUR$7,500USD£5,844GBP
- Report
- April 2023
- 240 Pages
Global
From €3100EUR$3,500USD£2,727GBP
- Report
- August 2024
- 141 Pages
Global
From €2656EUR$2,999USD£2,337GBP
- Report
- March 2024
- 200 Pages
Global
From €3676EUR$4,150USD£3,234GBP
- Report
- May 2024
- 182 Pages
Global
From €3986EUR$4,500USD£3,506GBP
- Report
- February 2024
- 110 Pages
Global
From €4207EUR$4,750USD£3,701GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more